MoneyWorks4Me

Gujarat Themis strengthens on plan to manufacture & supply products to Lupin on revised terms

10 Feb 2015 Evaluate

Gujarat Themis Biosyn is currently trading at Rs. 26.05, up by 1.20 points or 4.83 % from its previous closing of Rs. 24.85 on the BSE.

The scrip opened at Rs. 23.65 and has touched a high and low of Rs. 26.05 and Rs. 23.65 respectively. So far 62681 shares were traded on the counter.

The BSE group 'T' stock of face value Rs. 5 has touched a 52 week high of Rs. 27.90 on 06-Feb-2015 and a 52 week low of Rs. 9.00 on 15-May-2014.

Last one week high and low of the scrip stood at Rs. 27.90 and Rs. 24.85 respectively. The current market cap of the company is Rs. 37.85 crore.

The promoters holding in the company stood at 74.99%, while Institutions and Non-Institutions held 0.03% and 24.97% respectively.

Gujarat Themis Biosyn has entered into an agreement for manufacturing & supply of finish product to Lupin on revised terms during the period April 01, 2015 to March 31, 2018.

Gujarat Themis Biosyn is a biotech and synthetic product manufacturing company, having plants at Vapi, Hyderabad, with group turnover of over $40 million. The company has world-wide exports to satisfied customers, having customised facility for all products.

Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..